VD
Verneuil Vanina de
EVP, General Counsel, Corp Sec

Verneuil Vanina de insider trades: Vir Biotechnology (VIR) stock sales

EVP, General Counsel, Corp Sec, Vir Biotechnology Last trade Nov 3, 2026 9 Form 4 filings
$75K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2024
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Verneuil reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 3, 2026VIR↓ Sell$42K
Feb 23, 2026VIR↓ Sell$33K
Nov 5, 2025VIR↓ Sell$12K
Nov 3, 2025VIR↓ Sell$8K
Feb 26, 2025VIR↓ Sell$67K
Feb 24, 2025VIR↓ Sell$49K
Dec 2, 2024VIR↓ Sell$625
Nov 6, 2024VIR↓ Sell$44K
Nov 5, 2024VIR↓ Sell$32K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other VIR insiders

Open-market trades in the last 12 months

About Verneuil Vanina de's insider trades

Verneuil Vanina de is EVP, General Counsel, Corp Sec at Vir Biotechnology (VIR). Since Nov 5, 2024, Verneuil has reported no open-market purchases and 9 sales worth $289K on SEC Form 4. In the last 12 months: 2 sales ($75K).

Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VIR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.